AI assistant
Sending…
VERU INC. — Director's Dealing 2012
Dec 11, 2012
34598_dirs_2012-12-11_ba2226b3-705c-474c-a066-d201b6580d5d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FEMALE HEALTH CO (FHCO)
CIK: 0000863894
Period of Report: 2012-12-07
Reporting Person: DEARHOLT STEPHEN M (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-07 | Common Stock, par value $.01 per share | S | 42906 | $6.9 | Disposed | 2361560 | Direct |
| 2012-12-10 | Common Stock, par value $.01 per share | S | 40000 | $6.9053 | Disposed | 2321560 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $.01 per share | 125150 | Indirect |
| Common Stock, par value $.01 per share | 61812 | Indirect |
| Common Stock, par value $.01 per share | 400000 | Indirect |
Footnotes
F1: The price reported above is the weighted average transaction price. The range of prices for such transactions is $6.90 to $6.93. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
F2: Shares are held by the reporting person's self-directed IRA.
F3: Shares are held by a trust, of which the reporting person is a trustee
F4: Shares are held by a trust, of which the reporting person is a trustee.
More from VERU INC.
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 13
Major Shareholding Notification
2026
Feb 17
Regulatory Filings
2026
Feb 11